Bradley M. Fluegel - Sep 20, 2023 Form 4 Insider Report for American Oncology Network, Inc. (DTOC)

Role: Director
Signature: /s/ Bradley Fluegel
Stock symbol: DTOC
Transactions as of: Sep 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/20/2023, 09:04 PM
Previous filing: Aug 4, 2023
Next filing: Jan 22, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTOC	Class A Common Stock	Other	$0	+25K		$0.00	25K	Sep 20, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Class B common stock converted into shares of Class A common stock of American Oncology Network, Inc. through a series of transactions pursuant to that certain Business Combination Agreement, dated June 14, 2023, as amended, by and among the Issuer, American Oncology Network, LLC, a Delaware limited liability company, GEF AON Holdings Corp., a Delaware corporation, and DTOC Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Issuer.

Content

Represents Class B common stock converted into shares of Class A common stock of American Oncology Network, Inc. through a series of transactions pursuant to that certain Business Combination Agreement, dated June 14, 2023, as amended, by and among the Issuer, American Oncology Network, LLC, a Delaware limited liability company, GEF AON Holdings Corp., a Delaware corporation, and DTOC Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Issuer.